Our experts keep on top of the markets to bring you the latest on what's shaking up stock prices.
3 August 2022: Moderna has released its second quarterly earnings report which beat analyst expectations. It brought in $4.7 billion (£3.87 billion) in sales over the quarter, most of which can be cited to its COVID-19 vaccine. The company also announced that it's taken a $500 million (£411 million) hit from writing off vaccines that are out of date or will become out of date before they'll be used. Moderna reported its earnings per share (EPS) to be $5.24 (£4.32), above forecasts from analysts.
Moderna is a US biotechnology company. Its COVID-19 vaccine was approved for use in the UK on 8 January, 2021 - the third vaccine to get this approval. Moderna is expanding its production capability in Europe and UK supplies are expected in spring 2021. Moderna's share price rose after it announced encouraging early results from vaccine trials in November 2020, so news of an approved vaccine could see the share price rise further. The company uses a molecule called "messenger RNA" (or mRNA), which exists in the cells in your body, to produce medicines. We've compiled what you need to know about how to buy Moderna shares.
Moderna Inc (MRNA) is a publicly traded biotechnology business based in the US. In the week up to 7 August Moderna shares surged 13.86% to a closing position of $186.84. However, over the last 12 months, Moderna's share price has fallen by an alarming 61.09% from $375.53. Moderna is listed on the NASDAQ and employs 3,400 staff. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Mobile app
Best for
US shares
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £3.09 £620.95 total |
Capital at risk |
|
£0 | £250 | £11.59 £629.45 total |
Capital at risk |
 |
£0 | £1 | £2.78 £620.64 total |
Capital at risk |
|
£0 | No minimum | £6.18 £624.04 total |
Capital at risk |
 |
£0 | £1 | £18.13 £635.99 total |
Capital at risk |
 |
£0 | £0.01 | £0.62 £618.47 total |
Capital at risk |
 |
£9.99 per month | No minimum | £17.26 £635.11 total |
Capital at risk |
 |
£0 | £50 | £3.09 £620.95 total |
Capital at risk |
 |
£36 per year | £20 | £17.22 £635.08 total |
Capital at risk |
Full comparison of share dealing platforms
Historical closes compared with the last close of $146.1
| 1 week (2022-08-12) | -14.65% |
|---|---|
| 1 month (2022-07-19) | -12.59% |
| 3 months (2022-05-19) | 1.90% |
| 1 year (2021-08-19) | -61.09% |
|---|---|
| 2 years (2020-08-19) | 114.85% |
| 3 years (2019-08-19) | 990.30% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
Moderna's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Moderna shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Moderna's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $15.9 billion (£13.5 billion).
The EBITDA is a measure of a Moderna's overall financial performance and is widely used to measure a its profitability.
| Open | $147.64 |
|---|---|
| High | $150.75 |
| Low | $144.99 |
| Close | $146.1 |
| Previous close | $150 |
| Change | $-3.9 |
| Change % | -2.6% |
| Volume | 4,611,200 |
| 52-week range | $115.61 - $464.85 |
|---|---|
| 50-day moving average | $156.2026 |
| 200-day moving average | $185.1709 |
| Wall St. target price | $221.4 |
| PE ratio | 5.4799 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $32.26 |
We're not expecting Moderna to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (Moderna had its IPO on 7 December 2018). However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Moderna's shares have ranged in value from as little as $115.61 up to $464.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Moderna's is 1.6014. This would suggest that Moderna's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Investing in shares gives you the right to vote in important company decisions. Here are the key things you need to know about stock voting rights.
Find out how to invest in startups, how long it could take to get your money and why start up investing is so risky.
Find out how stock exchanges work and how they protect investors as well as help companies raise finance.
Demo trading accounts give investors the chance to test out different trading strategies in a risk-free environment. Here’s how they work.
Ever wondered how to buy shares in Honda? We explain how and compare a range of providers that can give you access to many brands, including Honda.
You can own Duolingo shares in just a few minutes by using an online share dealing platform. Our table lets you compare the UK’s leading share dealing accounts to find the right one for you.
“Earnings season” is the unofficial term for the period in which companies report their earnings for the latest quarter. Here’s what we’re expecting to see.
Find out the top 10 most popular stock market myths and whether or not there’s any truth to them.
Find out how you can sell your shares in the UK.
Ever wondered how to buy shares in Panasonic? We explain how and compare a range of providers that can give you access to many brands, including Panasonic.
